Euroseas Ltd. (NASDAQ:ESEA) Sky Rocket on Signed An Contract to Acquire From Dayang Shipyard- H&R Block (NYSE:HRB)

Euroseas Ltd. (NASDAQ:ESEA) persists its position slightly strong in context of buying side, while shares price shows upbeat performance surged 9.42% during latest trading session. Euroseas Ltd. (ESEA ) reported that it signed an contract to acquire from Dayang shipyard, Hull DY160, an Ultramax drybulk carrier, of 63,500 dwt built 2017. The vessel is expected to be delivered to the Company in January 2017 subject to a successful inspection by the Company by December 27, 2016; it will be acquired for approximately 62% of its contracted price in early 2014.

Aristides Pittas, Chairman and CEO of Euroseas commented: “We are extremely pleased to announce the acquisition of Alexandros P, an Ultramax drybulk carrier the construction of which we have supervised over the last two years; the vessel is a modern eco-ship incorporating the latest regulatory requirements and technological advances. Alexandros P alongside with our Kamsarmax newbuilding, Xenia, which we took delivery of earlier in 2016, spearhead the renewal of our drybulk fleet in anticipation of a recovery in the drybulk market. The conclusion of this contract also settles our claim against the yard in the best possible way and equips us with a solid balance sheet as we look forward to leveraging opportunities in the market.”

Narrow down focus to other ratios, the co has current ratio of 2.60 that indicates if ESEA lies in 1.3% to 3% then it is acceptable for both active and passive investors, but sometimes its varies industry to industry. Generally, it indicates good short-term financial strength. Street is more conscious on this after SunEdison, Inc. case. To make strengthen these views, the active industry firm has Quick Ratio of 2.40, which indicates firm has sufficient short-term assets to cover its immediate liabilities.

Following previous ticker characteristics, H&R Block, Inc. (NYSE:HRB) also run on active notice, stock price eased up 0.04% after traded at $23.21 in most recent trading session.

HRB has price to earnings ratio of 15.46 and the price to current year EPS stands at -13.00%. Whereas the traders who further want to see about this, may be interested to see Price to next year’s EPS that would be 5.76%. The earning yield also gives right direction to lure investment, as the co has 3.79% dividend yield. Moving toward ratio analysis, it has current ratio of 1.60 and quick ratio was calculated as 1.60.

Taking notice on volatility measures, price volatility of stock was 1.81% for a week and 2.92% for a month. The price volatility’s Average True Range for 14 days was 0.71. On these bases, analysts would recommend this stock as an “Active Revolving Stocks.” The firm attains analyst recommendation of 2.90 out of 1-5 scale with week’s performance of -0.22%. HRB’s institutional ownership was registered as 88.40%, while insider ownership was 0.80%.


About Gerard Bergeron

Gerard Bergeron covers Bio-pharmacy or healthcare sector Press Releases news updates. He has extensive three year of experience in content writing as freelance writer. He performs analysis of Healthcare Companies and provides worthy information for investor community. He is an experienced writer with a precise grasp of the English language and a clear, compelling writing style.

Leave a Reply

Your email address will not be published. Required fields are marked *